{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:23:39Z","timestamp":1759530219643},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Neuropeptide S (NPS) is a novel central acting neuropeptide that modulates several brain functions. NPS has shown strong anxiolytic-like effects and interactions with other central transmitter systems, including serotonin and glutamate. A coding variation (Asn107Ile) of the NPS receptor gene (NPSR1) was associated with panic disorder and schizophrenia. Based on these encouraging findings, the present study aimed at exploring a potential role of NPSR1 in obsessive\u2013compulsive disorder (OCD). A sample of 232 OCD patients was successfully genotyped for the NPSR1 Asn107Ile variant (rs324981). Age at onset was taken into account to address the heterogeneity of the OCD phenotype. The NPSR1 genotype significantly affected age at onset of the OCD patients, with a mean age at onset approximately 4 yr earlier in homozygous carriers of the low-functioning Asn107 variant compared to patients with at least one Ile107 variant (p = 0.032). Case\u2013control analyses with 308 healthy control subjects reveal a highly significant association of the Asn107 variant with early onset OCD (odds ratio = 2.36, p = 0.0004) while late onset OCD or the OCD group as a whole were unrelated to the NPSR1 genotype. Based on our association finding relating NPSR1 genotype to early onset OCD, we suggest a differential role of the NPS system in OCD. In particular, the early onset OCD subtype seems to be characterized by a genetically driven low NPS tone, which might affect other OCD-related transmitter systems, including the serotonin and glutamate systems. In agreement with preclinical research, we suggest that NPS may be a promising pharmacological candidate with anti-obsessional properties.<\/jats:p>","DOI":"10.1017\/s1461145713000382","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T11:52:05Z","timestamp":1368791525000},"page":"1951-1958","source":"Crossref","is-referenced-by-count":7,"title":["The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) influences age at onset of obsessive\u2013compulsive disorder"],"prefix":"10.1093","volume":"16","author":[{"given":"Leonhard","family":"Lennertz","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra E.","family":"Franke","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J\u00f6rgen","family":"Grabe","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Greifswald, Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike","family":"Rampacher","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svenja","family":"Schulze-Rauschenbach","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Guttenthaler","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Ruhrmann","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Pukrop","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Klosterk\u00f6tter","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Munich, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Maier","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainald","family":"M\u00f6ssner","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,10,1]]},"reference":[{"key":"2019101113494122800_ref1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00004714-200206000-00012","article-title":"Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder","volume":"22","author":"Ackerman","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"2019101113494122800_ref2","doi-asserted-by":"publisher","first-page":"e29523","DOI":"10.1371\/journal.pone.0029523","article-title":"Multiple polymorphisms affect expression and function of the neuropeptide S receptor (NPSR1)","volume":"6","author":"Anedda","year":"2011","journal-title":"PLoS ONE"},{"key":"2019101113494122800_ref3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1086\/424390","article-title":"A powerful strategy to account for multiple testing in the context of haplotype analysis","volume":"75","author":"Becker","year":"2004","journal-title":"Am J Hum Genet"},{"key":"2019101113494122800_ref4","doi-asserted-by":"publisher","first-page":"24704","DOI":"10.1074\/jbc.M603691200","article-title":"Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I","volume":"281","author":"Bernier","year":"2006","journal-title":"J Biol Chem"},{"key":"2019101113494122800_ref5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15288\/jsa.1994.55.149","article-title":"A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA","volume":"55","author":"Bucholz","year":"1994","journal-title":"J Stud Alcohol"},{"key":"2019101113494122800_ref6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1586\/ern.09.36","article-title":"Endophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential","volume":"9","author":"Chamberlain","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"2019101113494122800_ref7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jad.2005.12.011","article-title":"Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder","volume":"91","author":"Denys","year":"2006","journal-title":"J Affect Disord"},{"key":"2019101113494122800_ref8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.euroneuro.2005.12.001","article-title":"Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males","volume":"16","author":"Denys","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"2019101113494122800_ref9","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/archpsyc.63.7.778","article-title":"Association testing of the positional and functional candidate gene SLC1A1\/EAAC1 in early-onset obsessive-compulsive disorder","volume":"63","author":"Dickel","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113494122800_ref10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.biopsych.2006.09.030","article-title":"Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder","volume":"61","author":"Dickel","year":"2007","journal-title":"Biol Psychiatry"},{"key":"2019101113494122800_ref11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4088\/JCP.v65n0104","article-title":"Impact of age at onset and duration of illness on the expression of comorbidities in obsessive-compulsive disorder","volume":"65","author":"Diniz","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"2019101113494122800_ref12","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1176\/appi.ajp.158.11.1899","article-title":"Adults with early-onset obsessive-compulsive disorder","volume":"158","author":"do Rosario-Campos","year":"2001","journal-title":"Am J Psychiatry"},{"key":"2019101113494122800_ref13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ajmg.b.30149","article-title":"A family study of early-onset obsessive-compulsive disorder","volume":"136B","author":"do Rosario-Campos","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2019101113494122800_ref14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/mp.2010.81","article-title":"Neuropeptide S receptor gene \u2013 converging evidence for a role in panic disorder","volume":"16","author":"Domschke","year":"2011","journal-title":"Mol Psychiatry"},{"key":"2019101113494122800_ref15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cpr.2004.08.004","article-title":"A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder","volume":"24","author":"Eddy","year":"2004","journal-title":"Clin Psychol Rev"},{"key":"2019101113494122800_ref16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neulet.2010.03.028","article-title":"Intra-amygdala injections of neuropeptide S block fear-potentiated startle","volume":"474","author":"Fendt","year":"2010","journal-title":"Neuroscience Letters"},{"key":"2019101113494122800_ref17","volume-title":"Schudule of affective disorders and schizophrenia \u2013 lifetime version modified for the study of anxiety disorders (SADS-LA), updated for DSM-IV (SADS-LA-IV)","author":"Fyer","year":"1995"},{"key":"2019101113494122800_ref18","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/archpsyc.1989.01810110054008","article-title":"The Yale-Brown Obsessive Compulsive Scale. II. Validity","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113494122800_ref19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113494122800_ref20","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1176\/appi.ajp.163.11.1986","article-title":"Familiality of obsessive-compulsive disorder in nonclinical and clinical subjects","volume":"163","author":"Grabe","year":"2006","journal-title":"Am J Psychiatry"},{"key":"2019101113494122800_ref21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neulet.2009.03.023","article-title":"Neuropeptide S facilitates spatial memory and mitigates spatial memory impairment induced by N-methyl-d-aspartate receptor antagonist in mice","volume":"455","author":"Han","year":"2009","journal-title":"Neurosci Lett"},{"key":"2019101113494122800_ref22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ajmg.b.30138","article-title":"A family study of obsessive-compulsive disorder with pediatric probands","volume":"134B","author":"Hanna","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2019101113494122800_ref23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/bioinformatics\/btn581","article-title":"Genetic association analysis with FAMHAP: a major program update","volume":"25","author":"Herold","year":"2009","journal-title":"Bioinformatics"},{"key":"2019101113494122800_ref24","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/da.20597","article-title":"Early onset of obsessive-compulsive disorder and associated comorbidity","volume":"26","author":"Janowitz","year":"2009","journal-title":"Depress Anxiety"},{"key":"2019101113494122800_ref25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/BF01324255","article-title":"Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design","volume":"46","author":"John","year":"2001","journal-title":"Soz Praventivmed"},{"key":"2019101113494122800_ref26","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1017\/S1461145711001623","article-title":"The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response","volume":"15","author":"Lennertz","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"2019101113494122800_ref27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00213-008-1080-4","article-title":"Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders","volume":"197","author":"Leonard","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"2019101113494122800_ref28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.psychres.2010.08.030","article-title":"Association analysis of serotonin and catecholamine system candidate genes in obsessive-compulsive disorder in the Chinese population","volume":"188","author":"Liu","year":"2011","journal-title":"Psychiatry Res"},{"key":"2019101113494122800_ref29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.neubiorev.2007.09.005","article-title":"Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited","volume":"32","author":"Menzies","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"2019101113494122800_ref30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/sj.mp.4001617","article-title":"Obsessive-compulsive disorder phenotypes: implications for genetic studies","volume":"10","author":"Miguel","year":"2005","journal-title":"Mol Psychiatry"},{"key":"2019101113494122800_ref31","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1017\/S1461145705005997","article-title":"Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder","volume":"9","author":"M\u00f6ssner","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"2019101113494122800_ref32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.psc.2009.11.001","article-title":"Genetics of obsessive-compulsive disorder","volume":"33","author":"Nestadt","year":"2010","journal-title":"Psychiatr Clin North Am"},{"key":"2019101113494122800_ref33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/archpsyc.57.4.358","article-title":"A family study of obsessive-compulsive disorder","volume":"57","author":"Nestadt","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113494122800_ref34","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.pnpbp.2007.06.026","article-title":"Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit\/hyperactivity disorder","volume":"31","author":"Okamura","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2019101113494122800_ref35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neuropharm.2009.06.027","article-title":"Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801","volume":"58","author":"Okamura","year":"2010","journal-title":"Neuropharmacology"},{"key":"2019101113494122800_ref36","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/npp.2010.207","article-title":"Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain","volume":"36","author":"Okamura","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"2019101113494122800_ref37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuropharm.2009.06.001","article-title":"Neuropeptide S: a transmitter system in the brain regulating fear and anxiety","volume":"58","author":"Pape","year":"2010","journal-title":"Neuropharmacology"},{"key":"2019101113494122800_ref38","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1476-5381.2009.00163.x","article-title":"Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings","volume":"157","author":"Raiteri","year":"2009","journal-title":"Br J Pharmacol"},{"key":"2019101113494122800_ref39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/400_2007_051","article-title":"Neuropeptide S: anatomy, pharmacology, genetics and physiological functions","volume":"46","author":"Reinscheid","year":"2008","journal-title":"Results Probl Cell Differ"},{"key":"2019101113494122800_ref40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1124\/mi5.1.8","article-title":"Neuropeptide S: a new player in the modulation of arousal and anxiety","volume":"5","author":"Reinscheid","year":"2005","journal-title":"Mol Interv"},{"key":"2019101113494122800_ref41","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1124\/jpet.105.093427","article-title":"Pharmacological characterization of human and murine neuropeptide s receptor variants","volume":"315","author":"Reinscheid","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"2019101113494122800_ref42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/bjp.2008.96","article-title":"Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice","volume":"154","author":"Rizzi","year":"2008","journal-title":"Br J Pharmacol"},{"key":"2019101113494122800_ref43","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/01.chi.0000132812.44664.2d","article-title":"Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression vs. healthy controls","volume":"43","author":"Rosenberg","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2019101113494122800_ref44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol Psychiatry"},{"key":"2019101113494122800_ref45","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1471-4159.2010.06947.x","article-title":"Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex","volume":"115","author":"Si","year":"2010","journal-title":"J Neurochem"},{"key":"2019101113494122800_ref46","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.cpr.2011.06.007","article-title":"Early vs. late onset obsessive-compulsive disorder: evidence for distinct subtypes","volume":"31","author":"Taylor","year":"2011","journal-title":"Clin Psychol Rev"},{"key":"2019101113494122800_ref47","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1375\/twin.8.5.450","article-title":"Twin studies on obsessive-compulsive disorder: a review","volume":"8","author":"van Grootheest","year":"2005","journal-title":"Twin Res Hum Genet"},{"key":"2019101113494122800_ref48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archpsyc.61.6.597","article-title":"Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations","volume":"61","author":"Xu","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113494122800_ref49","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.neuron.2004.08.005","article-title":"Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects","volume":"43","author":"Xu","year":"2004","journal-title":"Neuron"},{"key":"2019101113494122800_ref50","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/cne.21159","article-title":"Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain","volume":"500","author":"Xu","year":"2007","journal-title":"J Comp Neurol"},{"key":"2019101113494122800_ref51","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/00048670802050546","article-title":"Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder","volume":"42","author":"Yucel","year":"2008","journal-title":"Aust N Z J Psychiatry"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/16\/9\/1951\/30135442\/16-9-1951.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/16\/9\/1951\/30135442\/16-9-1951.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T20:49:59Z","timestamp":1570826999000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/16\/9\/1951\/796121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,10,1]]}},"URL":"https:\/\/doi.org\/10.1017\/s1461145713000382","relation":{},"ISSN":["1469-5111","1461-1457"],"issn-type":[{"value":"1469-5111","type":"electronic"},{"value":"1461-1457","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,10]]},"published":{"date-parts":[[2013,10,1]]}}}